Nanoflex Robotics

Nanoflex Robotics is a medical robotics company that develops telerobotic solutions for critical endovascular interventions, starting with stroke treatment. The company technology uses advanced magnetic navigation and ultra-flexible microrobotic devices including magnetic catheters and guidewires to enable physicians to perform thrombectomies remotely, regardless of patient location. This approach addresses the geographical restrictions that prevent millions of people from receiving timely access to life-saving stroke interventions, where rapid treatment minimizes brain damage and improves recovery prospects. Nanoflex system combines magnetic navigation, robotic devices, and AI-compatible software to deliver borderless, transformative treatments for endovascular diseases. The company has conducted the first transatlantic remote animal thrombectomy study and was awarded 12.5 million from the EIC Accelerator. Founded in 2021 and headquartered in Zurich, Switzerland, Nanoflex Robotics has raised approximately $15.2 million in Series A funding from investors including Ascend Capital Partners, Kinled Holding, Mountain Labs, and Innosuisse.